This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Vitamin-deficiency anemia : Results from a lack of vitamin B12 or folic acid, both vital for producing red blood cells. Anemia of chronic disease : A type of anemia commonly seen in patients with long-term health conditions such as kidneydisease or heart disease.
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).
Join us as we examine the landmark approvals that are revolutionizing patient outcomes. Notes: Approved after initial rejection two years prior based on safety data from Japan, where the drug had been used since 2020 It can only be used in kidneydisease patients on dialysis for at least 3 months.
For example, kidneydisease is not included in CHA 2 DS 2 -VASc. This device sits in the heart’s left atrial appendage, where bloodclots often form, to prevent them from getting into the bloodstream.
Participating in any resistance training is associated with a 15%–17% lower risk for these outcomes compared to non-participation. Most data suggest that 30–60 minutes per week is sufficient to maximize the risk reduction — benefits start to plateau and then reverse after this threshold.
Participating in any resistance training is associated with a 15%–17% lower risk for these outcomes compared to non-participation. Most data suggest that 30–60 minutes per week is sufficient to maximize the risk reduction — benefits start to plateau and then reverse after this threshold.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content